A crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by cancer cells to put the brakes on the immune system, according to a new study from researchers. Researchers say this increased understanding can serve as a biomarker that helps predict which patients are likely to respond to immunotherapies. They also show how tipping the balance has potential implications for therapy itself, since blocking the signal in cancer cells helps the immune system fight off tumors in multiple pre-clinical cancer models. The study was published in Cell.
The study focused on the interferon (IFN) signaling pathway. Interferons normally help activate the immune system to protect cells from viruses and get their name because they literally interfere with a virus' ability to spread. However, IFNs can also put the brakes on the immune system.
"This paradoxical effect has been seen in other diseases - such as chronic viral infections - but our study shows how cancer cells take advantage of the suppressive properties of IFNs to interfere with cancer immunotherapy," said the study's senior author.
This study builds on previous research, which initially identified IFNs as having a role in cancer immunotherapy resistance. For the current study, researchers found when IFNs put a brake on the immune system, cancer cells intercept and manipulate that signal. However, when IFNs are allowed to send signals to the immune system, immune cells are able to do their jobs and kill tumors. Understanding this balance of how IFN signals are routed to immune versus cancer cells could provide a biomarker for whether immunotherapy can be effective.
"If we know the signaling is tilted toward immune cells or toward cancer, we may be able to better predict if a patient is likely to respond," the author said.
For cases where IFNs signal is stronger in cancer cells, there could be a therapeutic answer. Blocking the signal in tumors would only leave the "go" signal, freeing up the immune system to attack the cancer. That's exactly what happened when researchers tested the theory in pre-clinical models of melanoma, breast, and colorectal cancer treated with immunotherapies like PD-1 inhibitors or CAR T cells.
"IFN signaling exists in the majority of human cancers, so this could end up applying more broadly," the author said.
The next step is to figure out novel and safe ways to make IFNs' "go" signal stronger, or to block the "stop" signal. A trial testing that second approach in lung cancer patients is already enrolling patients.
https://www.pennmedicine.org/news/news-releases/2019/august/balance-of-stop-and-go-signaling-could-be-key-to-cancer-immunotherapy-response
https://www.cell.com/cell/fulltext/S0092-8674(19)30784-6
Modulating interferon signaling to control cancer immunotherapy response
- 1,781 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Genetic sex selection in mammals
Read more
A Novel Schizophrenia Risk Gene Identified!
Read more
Ancient epigenetic changes silence cancer-linked genes
Read more
Is anorexia 'metabo-psychiatric disorder'?
Read more
Similar noncoding CGC expansions found in different rare neurodegen…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar